JPMorgan Traders’ Math Places S&P 500 Near 6,300 By Month’s End
  • December 2, 2024

JPMorgan Traders’ Math Places S&P 500 Near 6,300 By Month’s End

(Bloomberg) -- Even after the strongest rally since the early days of the dot-com boom, the S&P 500 Index still has room to push higher through the end of the year, according to JPMorgan Chase & Co.’s trading desk.Most Read from BloombergRiyadh Metro Partially Opens in Bid to Ease City’s Traffic JamsAs Wars Rage, Cities Face a Dark New Era of Urban DestructionDerivatives analysts at the bank say the most popular options trades are wagering the US equity benchmark will hit 6,200 to 6,300 this mon

Why Is Senti Biosciences Stock Surging Over 400% On Monday?
  • December 2, 2024

Why Is Senti Biosciences Stock Surging Over 400% On Monday?

Senti Biosciences, Inc. (NASDAQ:SNTI) stock is skyrocketing on Monday, with a strong session volume of 73.4 million compared to an average volume of 17.81 thousand, as per data from Benzinga Pro. The company reported initial clinical data from a Phase 1 trial of SENTI-202, a potential first-in-class Logic Gated off-the-shelf chimeric antigen receptor natural killer (CAR-NK) investigational cell therapy, for relapsed/refractory hematologic malignancies including acute myeloid leukemia. SENTI-202

Advent Eyes New Mid-Market Strategy for Smaller Deals
  • December 2, 2024

Advent Eyes New Mid-Market Strategy for Smaller Deals

(Bloomberg) -- Buyout firm Advent is contemplating setting up an investment vehicle targeting mid-sized transactions as it looks to bolster its core private equity business.Most Read from BloombergRiyadh Metro Partially Opens in Bid to Ease City’s Traffic JamsAs Wars Rage, Cities Face a Dark New Era of Urban DestructionAdvent, which is focused on buying controlling stakes in businesses, raised $25 billion for its flagship buyout fund in 2022 — its largest fundraising to date. The firm sees a “fi